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STEREOSPECIFIC OPIATE BINDING IN 
HUMAN ERYTHROCYTE MEMBRANES AND 
CHANGES IN HEROIN ADDICTS 
Leo G. Abood, Holly G. Atkinson, and Mary MacNeil 
Center for Brain Research and Department of  Biochemistry, University of 
Rochester Medical Center, Rochester, New York 
Stereospecific opiate binding has been demonstrated in human erythrocyte mem- 
branes, having a Kd of 9 - lo-’ M. In most respects the binding characteristics 
resemble those of snyaptic membranes. These included the correlation of binding 
affinity and pharmacological potency of opiates; competition by naloxone; inhi- 
bition by Ca2+ and Na’; and sensitivity to phospholipases and trypsin. A com- 
parison of stereospecific opiate binding in control human subjects and heroin 
addicts revealed a 43% increase in the addict group. 
Key words: opiate binding, heroin addicts, erythrocytes, membranes 
In recent years, there has been considerable interest in the identification of the 
“opiate receptor” in brain tissue, and in the attempt to correlate the binding affinity of 
opiates to their pharmacological action (Goldstein et al., 1971; Pert and Snyder, 1973; 
Simon et al., 1973). Our interest in opiate binding developed from the observation that 
phosphatidyl serine not only exhibited stereospecific binding for opiates (Abood and 
Hoss, 197.9, but its addition to neural membrane preparations significantly enhanced 
stereospecific binding (Abood and Takeda, 1976). Since erythrocyte membranes contain 
a significant amount of phosphatidyl serine (Pasternak and Snyder, 1974), while the total 
lipid extract exhibits opiate binding, a study was undertaken to determine whether high 
affinity opiate binding occurred in the membranes. Initial attempts to demonstrate stereo- 
specific opiate binding to intact erythrocytes were unsuccessful, largely due to the fact 
that the hemoglobin, which leaked out into the incubation medium, was inhibitory to 
binding. The present study established that human erythrocyte membranes exhibit high 
affinity stereospecific binding for opiates, and that the binding site has many characteris- 
tics of the sites present in the brain tissue. In addition, a comparison was made of opiate 
binding in erythrocyte membranes of control subjects and heroin addicts. 
Address reprint requests to Leo G. Abood, Ph.D., Center for Brain Research, Box 605, 
University of Rochester Medical Center, Rochester, NY 14642. 
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Freshly drawn heparinized human blood was diluted with 5 volumes of 10 mM ice- 
cold Tris-EDTA, pH 7.5, and after 30 min was centrifuged at 100,000 g for 30 min. The 
pellet was homogenized in five times the original blood volume of 10 mM Tris-EDTA and 
recentrifuged. The washing procedure was repeated four times or until the hemoglobin had 
been removed. Stereospecific opiate binding was measured by the technique of Pert and 
Snyder (1973). A typical incubation medium contained the following in a final volume of 
1.2 ml: 0.05 M Tris, pH 7.5,0.05 pC of H-dihydromorphine (3 H-DHM), specific activity 
71 curies/mmole, and either M levorphanol or dextrorphan. After 15-min incuba- 
tion at 35"C, the samples were filtered by suction through a Whatman GF/B glass fiber 
filter, which was washed twice with 5 ml of ice-cold Tris buffer and transferred to a liquid 
scintillation vial for measuring radioactivity. All of the addicts used in the study were 
presently on heroin and had been on the drug for at least 1 year. The group consisted of 
seven males and three females ranging in age from 21 to 35 years. 
t o  those of brain tissue, the effect of a number of parameters known to influence the 
latter were examined (Table I). All values were expressed in terms of specific binding, 
which represented the difference in counts/min of the bound H-DHM in the presence of 
lop7 M dextrorphan from that in the presence of the experimental agent. At a concen- 
tration of 1 0-7 M hydromorphone produced complete inhibition and morphine 85%, 
In an effort to compare the opiate binding characteristics of erythrocyte membranes 
TABLE I. Effect of Various Treatments on  Binding of 3H-DHM to  Erythrocyte 
Membranes 
Dextorphan 
Levorphanol 
Hydromorphone 
Morphine 
Codeine 
Naloxone 
0.05 M NaCl 
Philpase A 
Philpase C 
Trypsin 
P-Serine 
M CaClz 
3H-DHM Specific Specific binding* 
bound binding, 
CPm 5% change '%brain change 
- - - 845 
602 243 
586 259 -106 -100 
638 207 - 85 - 90 
7 86 59 - 25 - 45 
713 45 - 18 - 95 
590 255 -104 - 95 
580 265 -109 -100 
6 10 235 - 97 - 90  
603 242 - 100 - 50 
552 293 -120 -100 
7 05 140 - 58 +3 5 
- - 
Membranes were exposed to  various treatments or drugs 30 min prior to  the addition 
of 3H-DHM. Incubation medium described in text; each tube containing 1.3 mg mem- 
brane protein. Amounts of phospholipase A (bee venom), phospholipase C (B. cereus) 
and trypsin (crystalline, treated with diphenyl carbamyl choline) was 1 unit, 2 units, 
and 0.2 mg respectively. Phosphatidyl serine was 99% pure (bovine brain) and used at 
a concentration of 100 p/mg protein. See (5) for details on use of enzymes and phos- 
phatidyl serine. 
*Specific binding: (243-column 2 ) .  100.  
243 
The values represent the mean of three separate experiments run in triplicate, and the 
variation from the mean was less than 6%. 
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values comparable to those obtained with rat brain synaptic membranes. Codeine, a weaker 
opiate, produced a 35% inhibition in erythrocytes as compared with 45% in the brain. On 
the other hand, the opiate antagonist naloxone had only a small effect on erythrocytes at 
a concentration completely inhibitory to brain. Both CaClz 
produced complete inhibition in both preparations, as did exposure to phospholipase A 
and trypsin. The erythrocyte appeared to be more sensitive to treatment with phospholi- 
pase C. Upon the addition of phosphatidyl serine (100 pg/mg membrane protein), binding 
was inhibited 58% as compared to a 35% enhancement of synaptic membranes. 
A Scatchard analysis was performed on the stereospecific opiate binding of erythro- 
cyte membranes from control human blood (Fig. 1). The Kd was calculated to  be 9 - 
M. This value compares with the lower affinity binding of brain tissue which ex- 
hibits a biphasic Scatchard plot with Kd s of 5 - lo-'' M and 8 - 
Takeda, 1976; Pasternak and Snyder, 1975). 
tained from a group of ten heroin addicts and an equal number of control subjects (Table 
11). The mean value of the control group was 130 k 25, with the range being 115-180. 
This compares with a mean of 202 k 38 in the addicts, with a range of 160-225. The mean 
is 43% greater in the addict than in the control group, the difference being significant at 
P < 0.01 (t test). It should be emphasized that the population of both control subjects 
and heroin addicts is too small to conclude that opiate binding increases during drug ad- 
diction; however, the data do encourage a more extensive study. 
M) and NaCl (0.05 M) 
M (Abood and 
A preliminary study was performed on the stereospecific binding of erythrocytes ob- 
10 20 
bound DHM moles ~ 1 0 ' '  
Fig. 1. Scatchard plot of 3Hdihydromorphine binding to human erythrocyte membranes. All assays 
were run in triplicate and represent two separate experiments. Binding is stereospecific, representing 
the difference in the presence of lo-' M levorphanol and dextorphan. Each tube contained 1 mg 
membrane protein in 0.05 M Tris, pH 7.5, and varying concentrations of 3Hdihydromorphine. The 
points are an average of three separate experiments run in triplicate; the variation from the mean being 
no more than 6%. 
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TABLE 11. Stereospecific Opiate Binding in Erythrocyte Membranes of 
Control Human Subjects and Heroin Addicts 
No. of 3H-DHM Range % 
subjects binding Increase 
CPm 
Controls 10 130 h 25 115-180 - 
Addicts 10 2 0 2 f 3 8  160-225 43* 
Stereospecific binding was expressed as difference in cpm of bound 
3H-DHM in the presence of 
presence of l o r 7  M levorphanol. Values are expressed as mean ? 
standard deviation counts/min/mg protein 
*Significant a t  P < O . O l  ( t  test). 
M dextrorphan from that in the 
The significance of the present study in terms of the pharmacological action of 
opiates is difficult to assess. It is, however, apparent that the characteristics of the opiate 
binding in erythrocyte membranes are very similar to those of brain tissue. Opiate bind- 
ing in both tissues is inhibited by phospholipase A or C as well as by trypsin and NaCl . 
The opiate antagonist naloxone is antagonistic t o  H-DHM binding in both preparations; 
however, the erythrocyte is only one-fifth as sensitive as synaptic membranes. Both Ca2+ and 
Na' are completely inhibitory to both types of membranes. There appears to be a rela- 
tionship between the affinity of various opiates and their pharmacological potency, hydro- 
morphone being the most potent opiate and codeine the least. A major difference was the 
effect of added phosphatidyl serine whch significantly enhanced opiate binding in brain 
tissue but was actually inhibitory to that in erythrocytes. Erythrocytes already contain a 
comparatively large proportion of phosphatidyl serine, as much as 20% of the total phos- 
pholipid (Rouser et al., 1968); consequently, all binding sites evidently have their comple- 
ment of this lipid. As discussed elsewhere (Abood and Takeda, 1976; Abood et al., in 
press), stereospecific opiate binding in neural membranes is significantly enhanced by 
phosphatidyl serine, a finding which suggests that phosphatidyl serine may be a compo- 
nent of the binding site. 
heroin addicts is based on only a few subjects, chronic drug usage is generally associated 
with a variety of adaptive mechanisms. The observation is also in conformity with the 
report that chronic administration of opiates to rats increases the number of opiate bind- 
ing sites in the brain (Pert and Snyder, 1976). 
binding site. At present the only plausible explanation for this difference is that the 
presence of the N-ally1 substituent on the opiate molecule tends to interfere with binding 
to the erythrocyte membrane. This conclusion is supported by the finding that N-allyl- 
morphine and levalorphan, which are also morphine antagonists, at concentrations of 
M do not interfere with H-DHM binding. It would appear that the reversal of 
opiate binding by antagonists, which is so characteristic of the brain receptor, is absent 
from erythrocytes. 
Although the observed increase in opiate binding in the erythrocyte membranes of 
A major difference was the inability of naloxone to compete for the erythrocyte 
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